Girish Mahajan (Editor)

Odalasvir

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
CAS Number
  
1458063-52-9

ChemSpider
  
34500837

3D model (Jmol)
  
Interactive image

Molar mass
  
1,001.264 g/mol

PubChem CID
  
71474517

UNII
  
OVR52K7BDW

Formula
  
C60H72N8O6

Legal status
  
US: Investigational New Drug

Odalasvir (INN, previously known as ACH-3102) is an investigational new drug in development for the treatment of hepatitis C. It is an NS5A inhibitor. The NS5A protein serves multiple functions at various stages of the viral life cycle, including viral replication. NS5A also plays a role in the development of interferon-resistance, a common cause of treatment failure.

References

Odalasvir Wikipedia